Rosemarie Truman

Rosemarie Truman is an entrepreneur, growth strategist, distinguished corporate executive, angel investor and prolific startup catalyst. Currently, Rosemarie is the Founder and CEO of the Center for Advancing Innovation (CAI), a 501c3 non-profit which has been coined “Tinder for Startups” and “Shark Tank on Steroids.” CAI’s mission is to identify breakthrough inventions and maximize their commercial potential.

Under Rosemarie’s leadership, CAI has earned numerous awards and recognition from Health and Human Services, the White House, the Federal Laboratory Consortium and more. CAI has also been featured in the Washington Post, Wired, Huffington Post, Nature, and several other publications.

Rosemarie’s specialty is growth and investment strategy, having led growth strategies for 50 of the global Fortune 100 companies in over 15 countries. The strategies that Rosemarie led have resulted in $300+ billion in “net new” top line yearly revenue and 190+ new products on the market.

At 19 years old, Rosemarie started her career as the first analyst hired by Goldman Sachs on the listed stock desk. Prior to launching her own firm, Rosemarie launched and led IBM’s Innovation strategy practice globally. At IBM, she was awarded IBM’s most laudable honor, the Golden Circle Award. In addition, she has also held notable leadership roles at Booz Allen Hamilton, Oracle, PRTM, and Marsh & McLennan, where she served as VP of global strategy for the largest brokerage firm in the world. Rosemarie’s core competencies are in leadership, strategy consulting, investment banking and entrepreneurship.

In her spare time, Rosemarie writes for Forbes and sits on company boards.

Education:
Double Major: Mathematics & industrial engineering operations research / economics
Double Minor: French & comparative literature
Thesis: Econometrics, software engineering- cloud computing
Mini MBA: Harvard and INSEAD